Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
Summary: There is increasing evidence that elimination strategies have resulted in better outcomes for public health, the economy, and civil liberties than have mitigation strategies throughout the first year of the COVID-19 pandemic. With vaccines that offer high protection against severe forms of...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | The Lancet Global Health |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X21004940 |
| _version_ | 1819177522458263552 |
|---|---|
| author | Miquel Oliu-Barton, PhD Bary S R Pradelski, PhD Yann Algan, ProfPhD Michael G Baker, ProfMD Agnes Binagwaho, ProfPhD Gregory J Dore, ProfPhD Ayman El-Mohandes, MD Arnaud Fontanet, ProfPhD Andreas Peichl, ProfPhD Viola Priesemann, PhD Guntram B Wolff, PhD Gavin Yamey, ProfMD Jeffrey V Lazarus, PhD |
| author_facet | Miquel Oliu-Barton, PhD Bary S R Pradelski, PhD Yann Algan, ProfPhD Michael G Baker, ProfMD Agnes Binagwaho, ProfPhD Gregory J Dore, ProfPhD Ayman El-Mohandes, MD Arnaud Fontanet, ProfPhD Andreas Peichl, ProfPhD Viola Priesemann, PhD Guntram B Wolff, PhD Gavin Yamey, ProfMD Jeffrey V Lazarus, PhD |
| author_sort | Miquel Oliu-Barton, PhD |
| collection | DOAJ |
| description | Summary: There is increasing evidence that elimination strategies have resulted in better outcomes for public health, the economy, and civil liberties than have mitigation strategies throughout the first year of the COVID-19 pandemic. With vaccines that offer high protection against severe forms of COVID-19, and increasing vaccination coverage, policy makers have had to reassess the trade-offs between different options. The desirability and feasibility of eliminating SARS-CoV-2 compared with other strategies should also be re-evaluated from the perspective of different fields, including epidemiology, public health, and economics. To end the pandemic as soon as possible—be it through elimination or reaching an acceptable endemic level—several key topics have emerged centring around coordination, both locally and internationally, and vaccine distribution. Without coordination it is difficult if not impossible to sustain elimination, which is particularly relevant in highly connected regions, such as Europe. Regarding vaccination, concerns remain with respect to equitable distribution, and the risk of the emergence of new variants of concern. Looking forward, it is crucial to overcome the dichotomy between elimination and mitigation, and to jointly define a long-term objective that can accommodate different political and societal realities. |
| first_indexed | 2024-12-22T21:28:00Z |
| format | Article |
| id | doaj.art-f8fc892828924ce795cd0901f5397ff9 |
| institution | Directory Open Access Journal |
| issn | 2214-109X |
| language | English |
| last_indexed | 2024-12-22T21:28:00Z |
| publishDate | 2022-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Global Health |
| spelling | doaj.art-f8fc892828924ce795cd0901f5397ff92022-12-21T18:12:00ZengElsevierThe Lancet Global Health2214-109X2022-01-01101e142e147Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccinesMiquel Oliu-Barton, PhD0Bary S R Pradelski, PhD1Yann Algan, ProfPhD2Michael G Baker, ProfMD3Agnes Binagwaho, ProfPhD4Gregory J Dore, ProfPhD5Ayman El-Mohandes, MD6Arnaud Fontanet, ProfPhD7Andreas Peichl, ProfPhD8Viola Priesemann, PhD9Guntram B Wolff, PhD10Gavin Yamey, ProfMD11Jeffrey V Lazarus, PhD12Université Paris-Dauphine–PSL, Paris, France; Bruegel, Brussels, Belgium; Esade Centre for Economic Policy, Madrid, Spain; Correspondence to: Dr Miquel Oliu-Barton, Université Paris-Dauphine–PSL, 75016 Paris, FranceFrench National Centre for Scientific Research, Grenoble, France; Oxford-Man Institute of Quantitative Finance, University of Oxford, Oxford, UKHEC Paris, Jouy-en-Josas, France; Council of Economic Analysis, Paris, FranceUniversity of Otago, Wellington, New ZealandUniversity of Global Health Equity, Kigali, RwandaKirby Institute, University of New South Wales, Sydney, NSW, AustraliaCity University of New York, New York, NY, USAEmerging Diseases Epidemiology Unit, Institut Pasteur, Université de Paris, Paris, France; Conservatoire National des Arts et Métiers, PACRI Unit, Paris, FranceUniversity of Munich, Munich, Germany; ifo Institute, Munich, Germany; CESifo, Munich, GermanyMax Planck Institute for Dynamics and Self-Organization, Göttingen, GermanyBruegel, Brussels, BelgiumCentre for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USABarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, SpainSummary: There is increasing evidence that elimination strategies have resulted in better outcomes for public health, the economy, and civil liberties than have mitigation strategies throughout the first year of the COVID-19 pandemic. With vaccines that offer high protection against severe forms of COVID-19, and increasing vaccination coverage, policy makers have had to reassess the trade-offs between different options. The desirability and feasibility of eliminating SARS-CoV-2 compared with other strategies should also be re-evaluated from the perspective of different fields, including epidemiology, public health, and economics. To end the pandemic as soon as possible—be it through elimination or reaching an acceptable endemic level—several key topics have emerged centring around coordination, both locally and internationally, and vaccine distribution. Without coordination it is difficult if not impossible to sustain elimination, which is particularly relevant in highly connected regions, such as Europe. Regarding vaccination, concerns remain with respect to equitable distribution, and the risk of the emergence of new variants of concern. Looking forward, it is crucial to overcome the dichotomy between elimination and mitigation, and to jointly define a long-term objective that can accommodate different political and societal realities.http://www.sciencedirect.com/science/article/pii/S2214109X21004940 |
| spellingShingle | Miquel Oliu-Barton, PhD Bary S R Pradelski, PhD Yann Algan, ProfPhD Michael G Baker, ProfMD Agnes Binagwaho, ProfPhD Gregory J Dore, ProfPhD Ayman El-Mohandes, MD Arnaud Fontanet, ProfPhD Andreas Peichl, ProfPhD Viola Priesemann, PhD Guntram B Wolff, PhD Gavin Yamey, ProfMD Jeffrey V Lazarus, PhD Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines The Lancet Global Health |
| title | Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines |
| title_full | Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines |
| title_fullStr | Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines |
| title_full_unstemmed | Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines |
| title_short | Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines |
| title_sort | elimination versus mitigation of sars cov 2 in the presence of effective vaccines |
| url | http://www.sciencedirect.com/science/article/pii/S2214109X21004940 |
| work_keys_str_mv | AT miqueloliubartonphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT barysrpradelskiphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT yannalganprofphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT michaelgbakerprofmd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT agnesbinagwahoprofphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT gregoryjdoreprofphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT aymanelmohandesmd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT arnaudfontanetprofphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT andreaspeichlprofphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT violapriesemannphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT guntrambwolffphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT gavinyameyprofmd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines AT jeffreyvlazarusphd eliminationversusmitigationofsarscov2inthepresenceofeffectivevaccines |